Tian Feng, Gao Xuejin, Zhang Li, Wang Xinying, Wan Xiao, Jiang Tingting, Wu Chao, Bi Jingcheng, Lei Qiucheng
Research Institute of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing 210002, China.
Department of General Surgery, South Medical University, Guangzhou 510515, China.
Nutrients. 2016 Sep 29;8(10):609. doi: 10.3390/nu8100609.
-3 polyunsaturated fatty acids (PUFAs) can improve the function of the intestinal barrier after damage from ischemia-reperfusion or hemorrhagic shock resuscitation (HSR). However, the effects of -3 PUFAs on intestinal microbiota and the innate immunity of the intestinal mucosa after HSR remain unclear. In the present study, 40 C57BL/6J mice were randomly assigned to five groups: control, sham, HSR, HSR + -3 PUFAs and HSR + -6 PUFAs. Mice were sacrificed 12 h after HSR. Liver, spleen, mesenteric lymph nodes and terminal ileal tissues were collected. Intestinal mucosae were scraped aseptically. Compared with the HSR group, the number of goblet cells increased, expression of mucin 2 was restored and disturbed intestinal microbiota were partly stabilized in the PUFA-administered groups, indicating that both -3 and -6 PUFAs reduced overproliferation of Gammaproteobacteria while promoting the growth of Bacteroidetes. Notably, -3 PUFAs had an advantage over -6 PUFAs in improving ileal tissue levels of lysozyme after HSR. Thus, PUFAs, especially -3 PUFAs, partly improved the innate immunity of intestinal mucosa in mice after HSR. These findings suggest a clinical rationale for providing -3 PUFAs to patients recovering from ischemia-reperfusion.
-3 多不饱和脂肪酸(PUFAs)可改善缺血再灌注或失血性休克复苏(HSR)损伤后肠道屏障的功能。然而,-3 PUFAs 对 HSR 后肠道微生物群和肠道黏膜固有免疫的影响仍不清楚。在本研究中,40 只 C57BL/6J 小鼠被随机分为五组:对照组、假手术组、HSR 组、HSR + -3 PUFAs 组和 HSR + -6 PUFAs 组。HSR 后 12 小时处死小鼠。收集肝脏、脾脏、肠系膜淋巴结和回肠末端组织。无菌刮取肠道黏膜。与 HSR 组相比,在给予 PUFA 的组中,杯状细胞数量增加,黏蛋白 2 的表达恢复,紊乱的肠道微生物群部分得到稳定,这表明 -3 和 -6 PUFAs 均减少了γ-变形菌的过度增殖,同时促进了拟杆菌的生长。值得注意的是,在 HSR 后提高回肠组织溶菌酶水平方面,-3 PUFAs 比 -6 PUFAs 具有优势。因此,PUFAs,尤其是 -3 PUFAs,部分改善了 HSR 后小鼠肠道黏膜的固有免疫。这些发现为向缺血再灌注恢复患者提供 -3 PUFAs 提供了临床依据。